Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A O'Donnell

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Seminars in Oncology|March 27, 2007
Advances in the management of superficial bladder cancerMichael A O'Donnell
Urologic Oncology|May 6, 2009
Optimizing BCG therapyMichael A O'Donnell
The Journal of Urology|November 2, 2022
Navigating the Treacherous Waters of Bacillus Calmette-Guérin FailureMichael A O'Donnell
Nature Clinical Practice. Oncology|September 7, 2006
Can a point-of-care urine protein assay monitor bladder cancer recurrence?Michael A O'donnell
Expert Review of Anticancer Therapy|December 23, 2003
Combined bacillus Calmette-Guerin and interferon use in superficial bladder cancerMichael A O'Donnell
Nature Clinical Practice. Urology|August 30, 2008
Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?Michael A O'Donnell
The Urologic Clinics of North America|May 3, 2005
Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancerMichael A O'Donnell
Cancer|April 22, 2009
When medical evidence alone is simply not enoughMichael A O'Donnell
World Journal of Urology|October 6, 2006
Treatment options for BCG failuresMichael A O'Donnell, Andreas Boehle
The Urologic Clinics of North America|November 24, 2019
Combination Intravesical TherapyNathan A Brooks, Michael A O'Donnell
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Seminars in Oncology|March 27, 2007
Advances in the management of superficial bladder cancerMichael A O'Donnell
Urologic Oncology|May 6, 2009
Optimizing BCG therapyMichael A O'Donnell
The Journal of Urology|November 2, 2022
Navigating the Treacherous Waters of Bacillus Calmette-Guérin FailureMichael A O'Donnell
Nature Clinical Practice. Oncology|September 7, 2006
Can a point-of-care urine protein assay monitor bladder cancer recurrence?Michael A O'donnell
Expert Review of Anticancer Therapy|December 23, 2003
Combined bacillus Calmette-Guerin and interferon use in superficial bladder cancerMichael A O'Donnell
Nature Clinical Practice. Urology|August 30, 2008
Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?Michael A O'Donnell
The Urologic Clinics of North America|May 3, 2005
Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancerMichael A O'Donnell
Cancer|April 22, 2009
When medical evidence alone is simply not enoughMichael A O'Donnell
World Journal of Urology|October 6, 2006
Treatment options for BCG failuresMichael A O'Donnell, Andreas Boehle
The Urologic Clinics of North America|November 24, 2019
Combination Intravesical TherapyNathan A Brooks, Michael A O'Donnell
Pageof 17